The PRECISE Study
for Oncology-Brain Cancer (GBM)
- Support patient retention in a 30-month mortality end-point study involving terminally ill patients with brain cancer.
- A comprehensive, sensitive VIP® (Very Important Patient) program for the study population and their families. The program addressed key issues facing these patients and their families in this end of life study.
- VIP program assisted study coordinators in establishing strong relations with study subjects and their families, assuring patient retention.